Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling

Franciscus Ginting, Adhi Kristianto Sugianli, Gidion Bijl, Restuti Hidayani Saragih, R. Lia Kusumawati, Ida Parwati, Menno D. de Jong, Constance Schultsz, Frank van Leth

Research output: Contribution to journalArticleAcademicpeer-review

Abstract

Global surveillance of antimicrobial resistance (AMR) is a key component of the 68th World Health Assembly Global Action Plan on AMR. Laboratory-based surveillance is inherently biased and lacks local relevance due to aggregation of data. We assessed the feasibility, sensitivity, and affordability of a population-based AMR survey using lot quality assurance sampling (LQAS), which classifies a population as having a high or low prevalence of AMR based on a priori defined criteria. Three studies were carried out in Medan and Bandung, Indonesia, between April 2014 and June 2017. LQAS classifications for 15 antibiotics were compared with AMR estimates from a conventional population-based survey, with an assessment of the cost of a single LQAS classification using microcosting methodology, among patients suspected of urinary tract infection at 11 sites in Indonesia. The sensitivity of LQAS was above 98%. The approach detected local variation in the prevalence of AMR across sites. Time to reach LQAS results ranged from 47 to 138 days. The average cost of an LQAS classification in a single facility was US$466. The findings indicate that LQAS-based AMR survey is a feasible, sensitive, and affordable strategy for population-based AMR surveys, providing essential data to inform local empirical treatment guidelines and antimicrobial stewardship efforts.
Original languageEnglish
Pages (from-to)734-742
JournalAmerican Journal of Epidemiology
Volume188
Issue number4
DOIs
Publication statusPublished - 2019

Cite this

Ginting, F., Sugianli, A. K., Bijl, G., Saragih, R. H., Kusumawati, R. L., Parwati, I., ... van Leth, F. (2019). Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling. American Journal of Epidemiology, 188(4), 734-742. https://doi.org/10.1093/aje/kwy276
Ginting, Franciscus ; Sugianli, Adhi Kristianto ; Bijl, Gidion ; Saragih, Restuti Hidayani ; Kusumawati, R. Lia ; Parwati, Ida ; de Jong, Menno D. ; Schultsz, Constance ; van Leth, Frank. / Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling. In: American Journal of Epidemiology. 2019 ; Vol. 188, No. 4. pp. 734-742.
@article{ccb9a8cd09814635bf920b74151892ce,
title = "Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling",
abstract = "Global surveillance of antimicrobial resistance (AMR) is a key component of the 68th World Health Assembly Global Action Plan on AMR. Laboratory-based surveillance is inherently biased and lacks local relevance due to aggregation of data. We assessed the feasibility, sensitivity, and affordability of a population-based AMR survey using lot quality assurance sampling (LQAS), which classifies a population as having a high or low prevalence of AMR based on a priori defined criteria. Three studies were carried out in Medan and Bandung, Indonesia, between April 2014 and June 2017. LQAS classifications for 15 antibiotics were compared with AMR estimates from a conventional population-based survey, with an assessment of the cost of a single LQAS classification using microcosting methodology, among patients suspected of urinary tract infection at 11 sites in Indonesia. The sensitivity of LQAS was above 98{\%}. The approach detected local variation in the prevalence of AMR across sites. Time to reach LQAS results ranged from 47 to 138 days. The average cost of an LQAS classification in a single facility was US$466. The findings indicate that LQAS-based AMR survey is a feasible, sensitive, and affordable strategy for population-based AMR surveys, providing essential data to inform local empirical treatment guidelines and antimicrobial stewardship efforts.",
author = "Franciscus Ginting and Sugianli, {Adhi Kristianto} and Gidion Bijl and Saragih, {Restuti Hidayani} and Kusumawati, {R. Lia} and Ida Parwati and {de Jong}, {Menno D.} and Constance Schultsz and {van Leth}, Frank",
year = "2019",
doi = "10.1093/aje/kwy276",
language = "English",
volume = "188",
pages = "734--742",
journal = "American Journal of Epidemiology",
issn = "0002-9262",
publisher = "Oxford University Press",
number = "4",

}

Ginting, F, Sugianli, AK, Bijl, G, Saragih, RH, Kusumawati, RL, Parwati, I, de Jong, MD, Schultsz, C & van Leth, F 2019, 'Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling' American Journal of Epidemiology, vol. 188, no. 4, pp. 734-742. https://doi.org/10.1093/aje/kwy276

Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling. / Ginting, Franciscus; Sugianli, Adhi Kristianto; Bijl, Gidion; Saragih, Restuti Hidayani; Kusumawati, R. Lia; Parwati, Ida; de Jong, Menno D.; Schultsz, Constance; van Leth, Frank.

In: American Journal of Epidemiology, Vol. 188, No. 4, 2019, p. 734-742.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Rethinking Antimicrobial Resistance Surveillance: A Role for Lot Quality Assurance Sampling

AU - Ginting, Franciscus

AU - Sugianli, Adhi Kristianto

AU - Bijl, Gidion

AU - Saragih, Restuti Hidayani

AU - Kusumawati, R. Lia

AU - Parwati, Ida

AU - de Jong, Menno D.

AU - Schultsz, Constance

AU - van Leth, Frank

PY - 2019

Y1 - 2019

N2 - Global surveillance of antimicrobial resistance (AMR) is a key component of the 68th World Health Assembly Global Action Plan on AMR. Laboratory-based surveillance is inherently biased and lacks local relevance due to aggregation of data. We assessed the feasibility, sensitivity, and affordability of a population-based AMR survey using lot quality assurance sampling (LQAS), which classifies a population as having a high or low prevalence of AMR based on a priori defined criteria. Three studies were carried out in Medan and Bandung, Indonesia, between April 2014 and June 2017. LQAS classifications for 15 antibiotics were compared with AMR estimates from a conventional population-based survey, with an assessment of the cost of a single LQAS classification using microcosting methodology, among patients suspected of urinary tract infection at 11 sites in Indonesia. The sensitivity of LQAS was above 98%. The approach detected local variation in the prevalence of AMR across sites. Time to reach LQAS results ranged from 47 to 138 days. The average cost of an LQAS classification in a single facility was US$466. The findings indicate that LQAS-based AMR survey is a feasible, sensitive, and affordable strategy for population-based AMR surveys, providing essential data to inform local empirical treatment guidelines and antimicrobial stewardship efforts.

AB - Global surveillance of antimicrobial resistance (AMR) is a key component of the 68th World Health Assembly Global Action Plan on AMR. Laboratory-based surveillance is inherently biased and lacks local relevance due to aggregation of data. We assessed the feasibility, sensitivity, and affordability of a population-based AMR survey using lot quality assurance sampling (LQAS), which classifies a population as having a high or low prevalence of AMR based on a priori defined criteria. Three studies were carried out in Medan and Bandung, Indonesia, between April 2014 and June 2017. LQAS classifications for 15 antibiotics were compared with AMR estimates from a conventional population-based survey, with an assessment of the cost of a single LQAS classification using microcosting methodology, among patients suspected of urinary tract infection at 11 sites in Indonesia. The sensitivity of LQAS was above 98%. The approach detected local variation in the prevalence of AMR across sites. Time to reach LQAS results ranged from 47 to 138 days. The average cost of an LQAS classification in a single facility was US$466. The findings indicate that LQAS-based AMR survey is a feasible, sensitive, and affordable strategy for population-based AMR surveys, providing essential data to inform local empirical treatment guidelines and antimicrobial stewardship efforts.

UR - https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85064139679&origin=inward

UR - https://www.ncbi.nlm.nih.gov/pubmed/30608516

U2 - 10.1093/aje/kwy276

DO - 10.1093/aje/kwy276

M3 - Article

VL - 188

SP - 734

EP - 742

JO - American Journal of Epidemiology

JF - American Journal of Epidemiology

SN - 0002-9262

IS - 4

ER -